Clinical response to antibiotic therapy for community-acquired pneumonia.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 14758544)

Published in Eur J Pediatr on January 31, 2004

Authors

Taina Juvén1, Jussi Mertsola, Matti Waris, Maija Leinonen, Olli Ruuskanen

Author Affiliations

1: Department of Paediatrics, Turku University Hospital, PL 52, 20521, Turku, Finland.

Articles cited by this

Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J (2000) 4.87

Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions. Lancet (1996) 4.22

Clinical efficacy of antimicrobial drugs for acute otitis media: metaanalysis of 5400 children from thirty-three randomized trials. J Pediatr (1994) 3.88

Community-acquired pneumonia in children. N Engl J Med (2002) 3.50

Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol (1993) 2.90

Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J (1995) 2.44

British Thoracic Society Guidelines for the Management of Community Acquired Pneumonia in Childhood. Thorax (2002) 2.25

Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics (2002) 2.08

Measurement of antibody responses to pneumolysin--a promising method for the presumptive aetiological diagnosis of pneumococcal pneumonia. J Infect (1989) 2.00

Pneumolysin PCR-based diagnosis of invasive pneumococcal infection in children. J Clin Microbiol (1999) 1.75

Differentiation of bacterial and viral pneumonia in children. Thorax (2002) 1.59

Diagnosis of Streptococcus pneumoniae lower respiratory infection in hospitalized children by culture, polymerase chain reaction, serological testing, and urinary antigen detection. Clin Infect Dis (2001) 1.25

Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children. Pediatr Infect Dis J (1998) 1.21

Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae. Pediatrics (1998) 1.20

Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents. Clin Infect Dis (2001) 1.19

Sinusitis in the common cold. J Allergy Clin Immunol (1998) 1.18

Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory-tract infections. Lancet Infect Dis (2001) 1.14

Pneumonia in childhood: etiology and response to antimicrobial therapy. Eur J Clin Microbiol Infect Dis (1992) 1.14

Chloramphenicol versus benzylpenicillin and gentamicin for the treatment of severe pneumonia in children in Papua New Guinea: a randomised trial. Lancet (2002) 1.09

Clinical efficacy of co-trimoxazole versus amoxicillin twice daily for treatment of pneumonia: a randomised controlled clinical trial in Pakistan. Arch Dis Child (2002) 1.08

Childhood community-acquired pneumonia. Semin Respir Infect (1999) 1.08

Bacteremic pneumococcal pneumonia in children. Clin Infect Dis (1999) 1.02

Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance. Clin Infect Dis (2001) 1.00

Management of patients with community-acquired pneumonia treated in hospital in Sweden. Scand J Infect Dis (2002) 0.96

Respiratory viruses interfere with bacteriologic response to antibiotic in children with acute otitis media. J Infect Dis (1990) 0.92

Fulminant pneumonia caused by concomitant infection with influenza B virus and Staphylococcus aureus. J Pediatr (1985) 0.89

The common cold: effects of intranasal fluticasone propionate treatment. J Allergy Clin Immunol (1998) 0.88

Etiology of pneumonia and other common childhood infections requiring hospitalization and parenteral antimicrobial therapy. SE-TU Study Group. Clin Infect Dis (1998) 0.82

Parenteral-oral switch in the management of paediatric pneumonia. Drugs (1994) 0.77

Antibiotic treatment of pediatric community-acquired lower respiratory tract infections: challenges and possible solutions. Respiration (1993) 0.75

Community-acquired pneumonia in children: guidelines for treatment. Pediatr Infect Dis J (2000) 0.75

Articles by these authors

Human bocavirus and acute wheezing in children. Clin Infect Dis (2007) 5.88

A placebo-controlled trial of antimicrobial treatment for acute otitis media. N Engl J Med (2011) 5.01

Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics (2004) 4.74

Metapneumovirus and acute wheezing in children. Lancet (2002) 3.64

Nasal swab versus nasopharyngeal aspirate for isolation of respiratory viruses. J Clin Microbiol (2002) 3.07

Symptoms or symptom-based scores cannot predict acute otitis media at otitis-prone age. Pediatrics (2010) 2.96

Coxsackievirus A6 and hand, foot, and mouth disease, Finland. Emerg Infect Dis (2009) 2.91

Serodiagnosis of human bocavirus infection. Clin Infect Dis (2008) 2.72

Respiratory picornaviruses and respiratory syncytial virus as causative agents of acute expiratory wheezing in children. Emerg Infect Dis (2004) 2.68

Rhinovirus-induced wheezing in infancy--the first sign of childhood asthma? J Allergy Clin Immunol (2003) 2.55

Prednisolone reduces recurrent wheezing after a first wheezing episode associated with rhinovirus infection or eczema. J Allergy Clin Immunol (2006) 2.46

Rhinovirus transmission within families with children: incidence of symptomatic and asymptomatic infections. J Infect Dis (2008) 2.36

Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis (2009) 2.36

Persistence of rhinovirus and enterovirus RNA after acute respiratory illness in children. J Med Virol (2004) 2.30

Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J (2005) 2.06

Microbiology of acute otitis media in children with tympanostomy tubes: prevalences of bacteria and viruses. Clin Infect Dis (2006) 2.06

Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland. Infect Immun (2005) 1.96

Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin Infect Dis (2003) 1.94

Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households. J Infect Dis (2002) 1.87

Clinical assessment and improved diagnosis of bocavirus-induced wheezing in children, Finland. Emerg Infect Dis (2009) 1.87

Etiological diagnosis of childhood pneumonia by use of transthoracic needle aspiration and modern microbiological methods. Clin Infect Dis (2002) 1.81

Human bocavirus-the first 5 years. Rev Med Virol (2011) 1.81

Influenza A and B virus infections in children. Clin Infect Dis (2003) 1.78

Immunity to pertussis 5 years after booster immunization during adolescence. Clin Infect Dis (2007) 1.77

Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio (2014) 1.76

Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis (2011) 1.74

Bordetella holmesii DNA is not detected in nasopharyngeal swabs from Finnish and Dutch patients with suspected pertussis. J Med Microbiol (2006) 1.69

Association of human bocavirus 1 infection with respiratory disease in childhood follow-up study, Finland. Emerg Infect Dis (2012) 1.67

Pneumonic vs nonpneumonic acute exacerbations of COPD. Chest (2002) 1.66

Ribosomal mutations in Streptococcus pneumoniae clinical isolates. Antimicrob Agents Chemother (2002) 1.63

Identification of respiratory viruses in asymptomatic subjects: asymptomatic respiratory viral infections. Pediatr Infect Dis J (2008) 1.57

Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland. Clin Vaccine Immunol (2012) 1.50

Antibiotic treatment of acute otorrhea through tympanostomy tube: randomized double-blind placebo-controlled study with daily follow-up. Pediatrics (2003) 1.47

Serum chlamydial lipopolysaccharide as a prognostic factor for a new cardiovascular event. Heart Lung (2008) 1.47

Seroepidemiology of human bocaviruses 1-4. J Infect Dis (2011) 1.37

Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. Microbes Infect (2005) 1.36

Factors contributing to pertussis resurgence. Future Microbiol (2008) 1.35

Serological evidence of Merkel cell polyomavirus primary infections in childhood. J Clin Virol (2010) 1.34

Atypical pathogen infection in adults with acute exacerbation of bronchial asthma. Am J Respir Crit Care Med (2002) 1.33

Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. Int J Cancer (2007) 1.32

Dating of human bocavirus infection with protein-denaturing IgG-avidity assays-Secondary immune activations are ubiquitous in immunocompetent adults. J Clin Virol (2010) 1.32

Size at birth, weight gain over the life course, and low-grade inflammation in young adulthood: northern Finland 1966 Birth Cohort study. Eur Heart J (2008) 1.32

Cold temperature and low humidity are associated with increased occurrence of respiratory tract infections. Respir Med (2008) 1.31

Bordetella pertussis protein pertactin induces type-specific antibodies: one possible explanation for the emergence of antigenic variants? J Infect Dis (2003) 1.29

Strain variation among Bordetella pertussis isolates in finland, where the whole-cell pertussis vaccine has been used for 50 years. J Clin Microbiol (2005) 1.28

Seroepidemiology of the newly found trichodysplasia spinulosa-associated polyomavirus. J Infect Dis (2011) 1.28

The hygiene hypothesis of atopic disease--an extended version. J Pediatr Gastroenterol Nutr (2004) 1.26

Comparative genomics of Bordetella pertussis reveals progressive gene loss in Finnish strains. PLoS One (2007) 1.26

Diagnosis of Streptococcus pneumoniae lower respiratory infection in hospitalized children by culture, polymerase chain reaction, serological testing, and urinary antigen detection. Clin Infect Dis (2001) 1.25

A comparative study of the etiology of adult upper and lower respiratory tract infections in the community. Diagn Microbiol Infect Dis (2002) 1.23

Rhinovirus-associated wheezing in infancy: comparison with respiratory syncytial virus bronchiolitis. Pediatr Infect Dis J (2004) 1.20

Use of an oligonucleotide array for laboratory diagnosis of bacteria responsible for acute upper respiratory infections. J Clin Microbiol (2004) 1.17

Human bocavirus in children with acute lymphoblastic leukemia. Eur J Pediatr (2007) 1.17

Merkel cell polyomavirus DNA in tumor-free tonsillar tissues and upper respiratory tract samples: implications for respiratory transmission and latency. J Clin Virol (2009) 1.14

New molecular virus detection methods and their clinical value in lower respiratory tract infections in children. Paediatr Respir Rev (2012) 1.13

The association between C-reactive protein levels and depression: Results from the northern Finland 1966 birth cohort study. Biol Psychiatry (2006) 1.13

Viral etiology of common cold in children, Finland. Emerg Infect Dis (2009) 1.13

C-reactive protein levels and sleep disturbances: observations based on the Northern Finland 1966 Birth Cohort study. Psychosom Med (2007) 1.12

Bronchiolitis: age and previous wheezing episodes are linked to viral etiology and atopic characteristics. Pediatr Infect Dis J (2009) 1.11

Bacterial and viral interactions within the nasopharynx contribute to the risk of acute otitis media. J Infect (2012) 1.10

Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population. Am J Obstet Gynecol (2008) 1.10

Influenza pneumonia. Pediatr Infect Dis J (2006) 1.08

Clinical effects of rhinovirus infections. J Clin Virol (2008) 1.08

Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia. J Allergy Clin Immunol (2010) 1.08

Incidence of influenza-related hospitalizations in different age groups of children in Finland: a 16-year study. Pediatr Infect Dis J (2011) 1.06

Temporal association between rhinovirus circulation in the community and invasive pneumococcal disease in children. Pediatr Infect Dis J (2011) 1.06

Risk of invasive pneumococcal infections among working age adults with asthma. Thorax (2010) 1.05

Bordetella pertussis, Finland and France. Emerg Infect Dis (2006) 1.05

Rhinovirus infections in children: a retrospective and prospective hospital-based study. J Med Virol (2009) 1.05

Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis. J Clin Microbiol (2007) 1.04

Respiratory viral infections in children with leukemia. Pediatr Infect Dis J (2008) 1.04

Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories. Vaccine (2006) 1.04

Synergistic effect of persistent Chlamydia pneumoniae infection, autoimmunity, and inflammation on coronary risk. Circulation (2003) 1.04

Respiratory syncytial virus infection in children hospitalized for wheezing: virus-specific studies from infancy to preschool years. Acta Paediatr (2005) 1.03

Bordetella pertussis isolates in Finland: serotype and fimbrial expression. BMC Microbiol (2008) 1.02

Seasonal patterns of viral and bacterial infections among children hospitalized with community-acquired pneumonia in a tropical region. Scand J Infect Dis (2010) 1.02

New respiratory viruses and the elderly. Open Respir Med J (2011) 1.02

Differences in the genomic content of Bordetella pertussis isolates before and after introduction of pertussis vaccines in four European countries. Infect Genet Evol (2011) 1.01

MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome. Ann Rheum Dis (2013) 0.99

Low-grade, systemic inflammation in adolescents: association with early-life factors, gender, and lifestyle. Am J Epidemiol (2009) 0.99

Real-time quantitative PCR for the detection of Streptococcus pneumoniae in the middle ear fluid of children with acute otitis media. Mol Cell Probes (2002) 0.98

Does the presence of pneumococcal DNA in middle-ear fluid indicate pneumococcal etiology in acute otitis media? J Infect Dis (2004) 0.98

Nasopharyngeal carriage of Streptococcus pneumoniae and pneumococcal urine antigen test in healthy elderly subjects. Scand J Infect Dis (2012) 0.97

Autoimmunity to human heat shock protein 60, Chlamydia pneumoniae infection, and inflammation in predicting coronary risk. Arterioscler Thromb Vasc Biol (2002) 0.97

Ultrasonography after the first febrile urinary tract infection in children. Eur J Pediatr (2006) 0.97

The role of respiratory viral infections among children hospitalized for community-acquired pneumonia in a developing country. Pediatr Infect Dis J (2008) 0.97